Physician profile
Jackson E Tillquist
NPI 1720442940
$1,609.23
in general payments reported to CMS, 2019-2025
18 companies · $443 in 2025
The $443 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $546 · 2022: $296 · 2023: $146 · 2024: $178 · 2025: $443.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $767.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $310.20 | 2021-2025 | Lifevest |
| Nuwellis, INC. | $278.44 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $150.14 | 2022-2024 | Jardiance |
| Cvrx, INC. | $130.28 | 2021 | |
| Abiomed | $116.48 | 2022 | |
| Novartis Pharmaceuticals Corporation | $96.96 | 2022-2025 | |
| Medtronic, INC. | $93.43 | 2024-2025 | Mycarelink, Corevalve Evolut R |
| Alnylam Pharmaceuticals INC. | $89.45 | 2025 | Onpattro |
| Novo Nordisk INC | $68.53 | 2025 | Wegovy |
| Amgen INC. | $64.48 | 2023-2024 | Repatha |
| Amarin Pharma, INC. | $60.79 | 2021-2022 | |
| Pfizer INC. | $41.89 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $26.25 | 2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $20.29 | 2023 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $17.31 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $16.78 | 2023 | Farxiga |
| Esperion Therapeutics, INC. | $16.26 | 2025 | Nexletol |
| Kowa Pharmaceuticals America, INC. | $11.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackson Tillquist listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.